| MicroRNA-30c-2* expressed in ovarian cancer cells suppresses growth factor-induced cellular proliferation and downregulates the oncogene BCL9. | ovarian, |
| Targeted disruption of the BCL9/beta-catenin complex inhibits oncogenic Wnt signaling. | None |
| LATS2 suppresses oncogenic Wnt signaling by disrupting beta-catenin/BCL9 interaction. | None |
| miR-30-5p functions as a tumor suppressor and novel therapeutic tool by targeting the oncogenic Wnt/beta-catenin/BCL9 pathway. | None |